HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey

Highlights COVID‐19 coinfection has improved in HIV‐infected cases that use regular ART and where viral load is suppressed, and even in advanced HIV‐infected cases without treatment. Although the data are not yet sufficient, the impression is that the presence of comorbidities is an important factor...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medical virology 2020-11, Vol.92 (11), p.2288-2290
Main Authors: Altuntas Aydin, Ozlem, Kumbasar Karaosmanoglu, Hayat, Kart Yasar, Kadriye
Format: Article
Language:English
Subjects:
Adult
Antibodies
Antiretroviral therapy
CD4 antigen
CD4 Lymphocyte Count
Coinfection - epidemiology
Coinfection - virology
Comorbidity
COVID-19
COVID-19 - diagnostic imaging
COVID-19 - epidemiology
HIV
HIV Infections - drug therapy
HIV Infections - epidemiology
Human immunodeficiency virus
Humans
Male
Public health
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Tomography, X-Ray Computed
Turkey - epidemiology
Virology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights COVID‐19 coinfection has improved in HIV‐infected cases that use regular ART and where viral load is suppressed, and even in advanced HIV‐infected cases without treatment. Although the data are not yet sufficient, the impression is that the presence of comorbidities is an important factor in mortality in HIV/SARS‐CoV‐2 coinfected cases. Radiological imaging findings were observed in all HIV‐infected cases, even in the case with very low CD4 cell count. And, with immunochromatographic antibody tests, it was observed that antibody formation time was similar to uninfected individuals.
ISSN:0146-6615
1096-9071
DOI:10.1002/jmv.25955